These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 11043500)

  • 21. Factor VIII von Willebrand factor antigen levels correlate with symptom severity in patients with Raynaud's phenomenon.
    Lau CS; McLaren M; Belch JJ
    Br J Rheumatol; 1991 Dec; 30(6):433-6. PubMed ID: 1747698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Endothelin-1 in pathogenesis of Raynaud's syndrome].
    Knapik-Kordecka M; Adamiec R; Ciosek W
    Pol Merkur Lekarski; 2001 Jun; 10(60):424-5. PubMed ID: 11503255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered circulating levels of adhesion molecules at 18 weeks' gestation among women with eventual preeclampsia: indicators of disturbed placentation in absence of evidence of endothelial dysfunction?
    Clausen T; Djurovic S; Brosstad FR; Berg K; Henriksen T
    Am J Obstet Gynecol; 2000 Feb; 182(2):321-5. PubMed ID: 10694331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis.
    Herrick AL; Illingworth K; Blann A; Hay CR; Hollis S; Jayson MI
    Ann Rheum Dis; 1996 Feb; 55(2):122-7. PubMed ID: 8712862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities.
    Ferri C; Desideri G; Baldoncini R; Bellini C; De Angelis C; Mazzocchi C; Santucci A
    Diabetes; 1998 Apr; 47(4):660-7. PubMed ID: 9568701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease.
    Tsakiris DA; Tschöpl M; Jäger K; Haefeli WE; Wolf F; Marbet GA
    Atherosclerosis; 1999 Jan; 142(1):193-200. PubMed ID: 9920521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Normal levels of soluble E-selectin, soluble intercellular adhesion molecule-1 (sICAM-1), and soluble vascular cell adhesion molecule-1 (sVCAM-1) decrease with age.
    Nash MC; Wade AM; Shah V; Dillon MJ
    Clin Exp Immunol; 1996 Jan; 103(1):167-70. PubMed ID: 8565278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent achievements in the management of Raynaud's phenomenon.
    Baumhäkel M; Böhm M
    Vasc Health Risk Manag; 2010 Apr; 6():207-14. PubMed ID: 20407628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelin, vasoconstriction, and endothelial damage in Raynaud's phenomenon.
    Cimminiello C; Milani M; Uberti T; Arpaia G; Perolini S; Bonfardeci G
    Lancet; 1991 Jan; 337(8733):114-5. PubMed ID: 1670699
    [No Abstract]   [Full Text] [Related]  

  • 30. Plasma soluble adhesion molecules; intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and E-selectin levels in patients with isolated coronary artery ectasia.
    Turhan H; Erbay AR; Yasar AS; Aksoy Y; Bicer A; Yetkin G; Yetkin E
    Coron Artery Dis; 2005 Feb; 16(1):45-50. PubMed ID: 15654200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of dipyridamole stress test on plasma levels of soluble adhesion molecules intracellular adhesion molecule-1, vascular cell adhesion molecule-1, E-selectin and L-selectin in patients with ischemic heart disease and patients with syndrome X.
    Siminiak T; Smielecki J; Rzeźniczak J; Kaźmierczak M; Kalawski R; Wysocki H
    Coron Artery Dis; 1999 Jun; 10(4):235-40. PubMed ID: 10376202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soluble cell adhesion molecules and von Willebrand factor in children with Kawasaki disease.
    Nash MC; Shah V; Dillon MJ
    Clin Exp Immunol; 1995 Jul; 101(1):13-7. PubMed ID: 7542571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible evidence of endothelial cell activation and disturbance in thalassemia: an in vitro study.
    Butthep P; Bunyaratvej A; Funahara Y; Kitaguchi H; Fucharoen S; Sato S; Bhamarapravati N
    Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 3():141-148A. PubMed ID: 9640617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. von Willebrand factor activity in primary and in scleroderma-associated Raynaud's phenomenon.
    Cuenca R; Fernadez-Cortijo J; Fonollosa V; Lima J; Simeon CP; Vilardell M; Pico M
    Lancet; 1990 May; 335(8697):1095. PubMed ID: 1970389
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasma soluble adhesion molecules and endothelium-dependent vasodilation in early human atherosclerosis.
    John S; Jacobi J; Delles C; Schlaich MP; Alter O; Schmieder RE
    Clin Sci (Lond); 2000 May; 98(5):521-9. PubMed ID: 10781382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute rejection before cytomegalovirus infection enhances von Willebrand factor and soluble VCAM-1 in blood.
    Kas-Deelen AM; Harmsen MC; De Maar EF; Oost-Kort WW; Tervaert JW; Van Der Meer J; Van Son WJ; The TH
    Kidney Int; 2000 Dec; 58(6):2533-42. PubMed ID: 11115088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Raynaud's phenomenon of the lung.
    Fahey PJ; Utell MJ; Condemi JJ; Green R; Hyde RW
    Am J Med; 1984 Feb; 76(2):263-9. PubMed ID: 6695950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of early endothelial damage in patients with Raynaud's phenomenon.
    Gualtierotti R; Ingegnoli F; Griffini S; Grovetti E; Borghi MO; Bucciarelli P; Meroni PL; Cugno M
    Microvasc Res; 2017 Sep; 113():22-28. PubMed ID: 28450106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Soluble cell adhesion molecules in chronic renal graft rejection].
    Boratyńska M
    Pol Arch Med Wewn; 1998 Nov; 100(5):410-8. PubMed ID: 10410574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency.
    Elhadd TA; Abdu TA; Oxtoby J; Kennedy G; McLaren M; Neary R; Belch JJ; Clayton RN
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4223-32. PubMed ID: 11549653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.